PCSA Processa Pharmaceuticals Inc

Price (delayed)

$2.78

Market cap

$7.65M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.4

Enterprise value

$5.95M

?
Relative Growth: Rel. Growth: 20
Relative Strength: Rel. Strength: 12
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2

Processa Pharmaceuticals, Inc. was founded in 2017 in Hanover, Maryland, with a mission to develop products that can improve the survival and/or quality of life for patients who have a ...

Highlights
PCSA's debt has dropped by 100% year-on-year
The EPS has soared by 88% YoY and by 9% from the previous quarter
Processa Pharmaceuticals's quick ratio has shrunk by 66% QoQ and by 62% YoY
Processa Pharmaceuticals's equity has shrunk by 54% QoQ and by 28% YoY

Key stats

What are the main financial stats of PCSA

PCSA stock price

How has the Processa Pharmaceuticals stock price performed over time
Intraday
-0.71%
1 week
5.3%
1 month
3.73%
1 year
-63.85%
YTD
-3.47%
QTD
10.1%

Financial performance

How have Processa Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.49M
Net income
-$14.11M
Gross margin
N/A
Net margin
N/A
Processa Pharmaceuticals's operating income has decreased by 19% YoY and by 3.6% QoQ
PCSA's net income is down by 18% YoY and by 4% QoQ

Price vs fundamentals

How does PCSA's price correlate with its fundamentals

Growth

What is Processa Pharmaceuticals's growth rate over time

Valuation

What is Processa Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 88% YoY and by 9% from the previous quarter
PCSA's P/B is 95% above its last 4 quarters average of 1.5 and 54% above its 5-year quarterly average of 1.9
Processa Pharmaceuticals's equity has shrunk by 54% QoQ and by 28% YoY

Efficiency

How efficient is Processa Pharmaceuticals business performance
The ROA has grown by 14% YoY but it has contracted by 5% from the previous quarter
Processa Pharmaceuticals's return on equity has increased by 12% YoY but it has decreased by 9% QoQ

Dividends

What is PCSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PCSA.

Financial health

How did Processa Pharmaceuticals financials performed over time
Processa Pharmaceuticals's total assets is 128% higher than its total liabilities
The current ratio has dropped by 67% year-on-year and by 61% since the previous quarter
Processa Pharmaceuticals's quick ratio has shrunk by 66% QoQ and by 62% YoY
PCSA's debt is 100% smaller than its equity
Processa Pharmaceuticals's debt to equity has plunged by 100% YoY
PCSA's debt has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.